As stratification with sex and age, the difference in the incidence rate of ischemic cerebrovascular disease between a benzbromarone group and a control group did not reach statistical significance. 3.3.
← all excerpts
The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan.
1
—
—